ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today announced that with immediate effect, its registered office address has been changed to: One Bartholomew Close, London, EC1A 7BL.
How Gut Bacteria May Impact Disease Development and Activity
New research findings offer interesting insights around the potential gut-lupus connection. The study’s results indicate people with lupus have reduced species diversity in their guts, meaning they have fewer types or strains of bacteria than those without lupus.